Replies to post #422 on Corcept Therapeutics, Inc. (CORT)

[north40000]

See Acad-Pharm.com for PR re phase 2 CTAD PR... news relating to dementia related psychosis treatment results with its BTD medication that is already approved for PD- related psychosis. CORT sp negative past few days...we hold both CORT and ACAD.